Edition:
United States

Endocyte Inc (ECYT.OQ)

ECYT.OQ on NASDAQ Stock Exchange Global Select Market

4.41USD
15 Dec 2017
Change (% chg)

$-0.20 (-4.34%)
Prev Close
$4.61
Open
$4.73
Day's High
$4.73
Day's Low
$4.30
Volume
1,300,769
Avg. Vol
519,170
52-wk High
$6.55
52-wk Low
$1.17

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.16 December 16 Dec 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 0
(2) OUTPERFORM 0 0 0 0
(3) HOLD 1 1 1 2
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.00 2.00 2.00 3.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 2 0.00 0.00 0.00 0.00
Quarter Ending Mar-18 2 0.00 0.00 0.00 --
Year Ending Dec-17 2 0.08 0.10 0.06 0.00
Year Ending Dec-18 2 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Dec-17 2 -0.16 -0.15 -0.16 -0.35
Quarter Ending Mar-18 2 -0.17 -0.17 -0.17 --
Year Ending Dec-17 2 -1.24 -1.23 -1.25 -1.17
Year Ending Dec-18 2 -0.90 -0.79 -1.02 -1.16

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 0.00 0.03 0.03 0.00
Quarter Ending Jun-17 0.00 0.01 0.01 0.00
Quarter Ending Mar-17 0.00 0.01 0.01 0.00
Quarter Ending Dec-16 0.00 0.01 0.01 0.00
Quarter Ending Sep-16 0.00 0.03 0.03 900.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 0.00 0.00 0.00 0.00 0.00
Quarter Ending Mar-18 0.00 0.00 0.00 0.00 --
Year Ending Dec-17 0.08 0.08 0.08 0.01 0.00
Year Ending Dec-18 0.00 0.00 0.00 0.00 0.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 0 0 0
Quarter Ending Mar-18 0 0 0 0
Year Ending Dec-17 0 0 0 0
Year Ending Dec-18 0 0 0 0
Earnings